Introduction
Hydroxyflutamide is a potent, nonsteroidal anti-androgen that has been reported to lack other agonistic or antagonistic hormonal properties (Neri et al, 1972) . It binds to androgen receptors and competitively inhibits the binding of testosterone and dihydrotestosterone. This compound has therefore been widely used as an anti-androgen in various studies (Peluso et al, 1980 ; Clark and Nowell, 1980; Krey et al, 1982; Armstrong et al, 1989) . Recent studies from our laboratories indicated that hydroxyflutamide blocks ovulation (Opavsky et al, 1987) through interference with the LH surge at pro-oestrus and is reversed by the administration of LHRH or progesterone on the day of pro-oestrus . In addition, hydroxyflutamide delays the initiation of implan¬ tation, fetal development and parturition in pregnant rats and suppresses decidualization after artificial stimulation of the sensitized uterus (Chandrasekhar et al, 1990 (Fig. 3) . In addition, the ability of oestradiol and progesterone, at 50 pg ml-1, to rescue mouse embryos from development arrest caused by 20 pg hydroxy¬ flutamide ml-1 was also tested. Oestradiol was ineffective in restoring the embryo development (Fig. 4) . However, progesterone had a positive effect; about 35% of the embryos developed to blastocysts (Fig. 4) . The embryo development, in the absence of hydroxyflutamide (Fig. 4) (Chandrasekhar et al, 1990; Chandrasekhar, 1991) . The delay in implantation of embryos in these studies (Chandrasekhar et al, 1990) appeared to be due to the effects of hydroxyflutamide on the uterus, as unimplanted embryos, flushed from the uterus on day 6 of preg¬ nancy, were at the blastocyst stage and when hydroxyflutamide treatment was terminated on day 6, these blastocysts went on to implant. In these studies (Chandrasekhar et al, 1990) (Chandrasekhar et al, 1990) suggests that this anti-androgen does not affect the ability of the embryo to implant. However, in the study reported here the early stages of embryo development were significantly arrested by hydroxy¬ flutamide. Data from this study together with our previous studies (Chandrasekhar et al, 1990; Chandrasekhar, 1991) raise the possibility that hydroxyflutamide may be used as an antigestational drug.
From these earlier studies in vivo (Chandrasekhar et al, 1990) it was unclear whether hydroxyflutamide had direct effects on embryo viability and its development. Results (Roblero, 1973; Roblero and Garavagno, 1979) 
